JaySSkylerMD

Endocrinology • Miami, FL

Diabetes, Lipid Metabolism

Professor of Medicine, University Miami School of Medicine

Join to view full profile

Dr. Skyler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Skyler's full profile

Already have an account?

Office
1450 Nw 10th Ave
Miami, FL 33136
Phone+1 305-243-3636

Fax+1 305-243-6575

Education & Training

Duke University HospitalResidency, Internal Medicine, 1970 - 1973
Duke University HospitalInternship, Transitional Year, 1969 - 1970
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1969

Certifications & Licensure

FL State Medical License 1976 - 2025
NC State Medical License 1972 - 1999
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com
Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1) Start of enrollment: 1994 Feb 01
Completed
Phase 3
TrialNet Pathway to Prevention of T1D Start of enrollment: 2004 Feb 01
Recruiting
New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial Start of enrollment: 2004 May 01
Completed
Phase 2
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials Start of enrollment: 2004 Nov 01
Completed
Not Applicable
T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus Start of enrollment: 2005 Sep 01
Completed
Nutritional Intervention to Prevent Diabetes Start of enrollment: 2006 Jun 01
Completed
Not Applicable
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus Start of enrollment: 2007 Feb 01
Completed
Phase 3
Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus Start of enrollment: 2008 Feb 01
Completed
Phase 2
Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset Subjects Start of enrollment: 2009 Feb 01
Completed
Phase 2
Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes Start of enrollment: 2010 Sep 01
Terminated
Phase 2, Phase 3
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk" Start of enrollment: 2010 Aug 01
Completed
Phase 2
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Start of enrollment: 2013 Mar 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

444 citations
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Kevan C. Herold, Brian N. Bundy, S. Alice Long, Jeffrey A. Bluestone, Linda A. DiMeglio
The New England Journal of Medicine. 2019-06-09
136 citations
Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial.
Barry E. Hurwitz, Johanna R. Klaus, Maria M. Llabre, Alex Gonzalez, Peter J. Lawrence
Archives of Internal Medicine. 2007-01-22
197 citations
Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials
Julio Rosenstock, Jan Marquard, Lori M. Laffel, Dietmar Neubacher, Stefan Kaspers
Diabetes Care. 2018-12-01

Press Mentions

How a Pioneering Diabetes Drug Offers Hope for Preventing Autoimmune DisordersFebruary 15th, 2023
The Diabetes Research Institute Appoints World-Renowned Diabetes Expert, Matthias Von Herrath, M.D., to Scientific DirectorJanuary 26th, 2023
Researchers to Report First Results from Highly Anticipated Type 1 Diabetes Intervention TrialMay 26th, 2022
Join now to see all

Grant Support

Type 1 Diabetes Trialnet: Support FacilitiesNational Institute Of Diabetes And Digestive And Kidney Diseases2007
Type 1 Diabetes TrialnetNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2004
Diabetes Prevention Trial-Iddm (Dpt-1)National Institute Of Diabetes And Digestive And Kidney Diseases1994–2000
Insulin Sensitivity, Blood Pressure, And Glucose ToleranceNational Heart, Lung, And Blood Institute1991–1995
Diabetes Prevention TrialNational Institute Of Diabetes And Digestive And Kidney Diseases1994
Prevention Of Type I Diabetes MellitusNational Institute Of Diabetes And Digestive And Kidney Diseases1993
Diabetes Mellitus: Pathogenesis And Immune InterventionNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1987
Diabetes Mellitus: Pathogenesis And Immune InterventionNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985